|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0024554,
umls-concept:C0031327,
umls-concept:C0164155,
umls-concept:C0681850,
umls-concept:C1512523,
umls-concept:C1550501,
umls-concept:C1556094,
umls-concept:C1556095,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2603343,
umls-concept:C2697811
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-4-27
|
|
pubmed:abstractText |
Pilsicainide hydrochloride is a class IC antiarrhythmic agent used for the treatment of supraventricular and ventricular arrhythmias.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
609-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19393851-Adult,
pubmed-meshheading:19393851-Anti-Arrhythmia Agents,
pubmed-meshheading:19393851-Area Under Curve,
pubmed-meshheading:19393851-Asian Continental Ancestry Group,
pubmed-meshheading:19393851-Chromatography, High Pressure Liquid,
pubmed-meshheading:19393851-Dose-Response Relationship, Drug,
pubmed-meshheading:19393851-Electrocardiography,
pubmed-meshheading:19393851-Humans,
pubmed-meshheading:19393851-Japan,
pubmed-meshheading:19393851-Korea,
pubmed-meshheading:19393851-Lidocaine,
pubmed-meshheading:19393851-Male,
pubmed-meshheading:19393851-Reference Values,
pubmed-meshheading:19393851-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects.
|
|
pubmed:affiliation |
Department of Pharmacology and Clinical Pharmacology, Seoul National University College of Medicine and Hospital, Jongno-gu, Seoul, Republic of Korea.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
